JavaScript is disabled for your browser. Some features of this site may not work without it.
Use of eCommons for rapid dissemination of COVID-19 research
In order to maximize the discoverability of COVID-19 research, and to conform with repository best practices and the requirements of publishers and research funders, we provide special guidance for COVID-19 submissions.
FDA Bioterrorism
| dc.contributor.author | Campbell, Doug | en_US |
| dc.date.accessioned | 2015-04-09T17:46:30Z | |
| dc.date.available | 2015-04-09T17:46:30Z | |
| dc.date.issued | 2006 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1813/39885 | |
| dc.subject | Bioterrorism | en_US |
| dc.title | FDA Bioterrorism | en_US |
